The effectiveness of tocilizumab in treating refractory adult-onset Still’s disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response-Reference-Cited by-同舟云学术

The effectiveness of tocilizumab in treating refractory adult-onset Still’s disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response

Published:2021-09-17 Issue:2 Volume:41 Page:557-566
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Tang Kuo-Tung,Hsieh Chia-Wei,Chen Hsin-Hua,Chen Yi-Ming,Chang Shih-Hsin,Huang Po-Hao,Lan Joung-Liang,Chen Der-Yuan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05921-2.pdf

Reference48 articles.

1. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M (1987) Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 14(6):1139–1146

2. Kadavath S, Efthimiou P (2015) Adult-onset Still’s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 47(1):6–14. https://doi.org/10.3109/07853890.2014.971052

3. Lenert A, Yao Q (2016) Macrophage activation syndrome complicating adult onset Still’s disease: a single center case series and comparison with literature. Semin Arthritis Rheum 45(6):711–716. https://doi.org/10.1016/j.semarthrit.2015.11.002

4. Yoo DH (2017) Treatment of adult-onset Still’s disease: up to date. Expert Rev Clin Immunol 13(9):849–866. https://doi.org/10.1080/1744666X.2017.1332994

5. Castaneda S, Blanco R, Gonzalez-Gay MA (2016) Adult-onset Still’s disease: advances in the treatment. Best Pract Res Clin Rheumatol 30(2):222–238. https://doi.org/10.1016/j.berh.2016.08.003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-18BP Therapy Ameliorates Reproductive and Metabolic Phenotypes in a PCOS Mouse Model by Relieving Inflammation, Fibrosis and Endoplasmic Reticulum Stress;Reproductive Sciences;2024-07-08

2. Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options;Drugs;2024-03

3. Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs;The Journal of Rheumatology;2024-02-01

4. Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience;Rheumatology and Therapy;2023-10-04

5. The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry;Seminars in Arthritis and Rheumatism;2023-10